Parole chiave di "Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease"

Label

• Parole chiave di "Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease" (literal)
• Keywords of "Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease" (literal)

Insieme di parole chiave di

• Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)

Ha membro

• Locomotion (Parola chiave)
• Anandamide (Parola chiave)
• CB1 receptor (Parola chiave)
• 2-Arachidonoylglycerol (Parola chiave)
• Cannabinoid (Parola chiave)

Incoming links:

Insieme di parole chiave

• Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)

Membro di

• 2-Arachidonoylglycerol (Parola chiave)
• Cannabinoid (Parola chiave)
• CB1 receptor (Parola chiave)
• Locomotion (Parola chiave)
• Anandamide (Parola chiave)